7 results
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... known or suspected malignant ... Official ATS/STS/STR Clinical ... #Malignant #Pleural ... Effusions #MPE #Algorithm
COVID-19 - A Seattle Intensivist's One-Page Cheat-Sheet on COVID-19 v2.7 Updated March 26 2020

(v2.7) incorporating newer
as data on new treatment ... illness) • 20-40% dyspnea ... numerous B-lines, pleural ... Cheatsheet #Diagnosis #Management ... #Summary #SARSCoV2
Possible Approach to Immunosuppression in Severe COVID-19

The diagnosis and treatment of cytokine storm remains unknown and
diagnosis and treatment ... Internet Book of Critical ... #management #schema ... #criticalcare #algorithm ... #SARSCOV2 #Coronavirus
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
with CTD, drugs, malignancy ... Organizing Pneumonia - Clinical ... History: cough, dyspnea ... Organizing Pneumonia Treatment ... ILD #diagnosis #management
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... known or suspected malignant ... Official ATS/STS/STR Clinical ... #Algorithm #Effusion ... #Malignant #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... hemoptysis • Dyspnea ... organ system: • Pleura ... tracheobronchial stenosis, malignancy ... TB #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... hemoptysis • Dyspnea ... organ system: • Pleura ... tracheobronchial stenosis, malignancy ... TB #Diagnosis #Management